BB Biotech AG (XTER:BBZA) Total Stockholders Equity : €2,370.5 Mil (As of Sep. 2024)

View and export this data going back to 2008. Start your Free Trial

What is BB Biotech AG Total Stockholders Equity?

BB Biotech AG's Total Stockholders Equity for the quarter that ended in Sep. 2024 was €2,370.5 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BB Biotech AG's Book Value per Share for the quarter that ended in Sep. 2024 was €43.24. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BB Biotech AG's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.12.

BB Biotech AG Total Stockholders Equity Historical Data

The historical data trend for BB Biotech AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Total Stockholders Equity Chart

BB Biotech AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

3,107.75

3,596.99

3,155.15

2,721.89

2,463.45

BB Biotech AG Quarterly Data
	Mar17	Jun17	Dec17	Dec18	Dec19	Dec20	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial															2,306.15	2,463.45	2,561.44	2,480.94	2,370.50

BB Biotech AG (XTER:BBZA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BB Biotech AG's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2370.501	-	0)	/	54.826
	=	43.24

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BB Biotech AG's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	291.719)	/	2370.501
	=	0.12

BB Biotech AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BB Biotech AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (XTER:BBZA) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

BIONz:UK BBZA:Germany BION:Switzerland BIOEE:Switzerland

Address

Schwertstrasse 6, Schaffhausen, CHE, CH-8200

Website

https://www.bbbiotech.com

BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system.

BB Biotech AG Headlines

No Headlines